As COVID-19 vaccines come online, fewer Americans want to take them
Americans’s interest in a COVID-19 vaccine is waning, with only 56% of adults saying they would get it if it were available. That’s down from 74% in April.
Related Articles
Anti-Aging Tech Mogul’s Fat Injection Goes Horribly Wrong
An allergic reaction left the anti-aging guru looking nearly unrecognizable.
Obesity in the US Projected to Skyrocket by 2050
If current trends continue, more than 250 million Americans will have overweight or obesity in the next quarter-century.
It Might Be Possible to Detect Gravitons After All | Quanta Magazine
A new experimental proposal suggests detecting a particle of gravity is far easier than anyone imagined. Now physicists are debating what it would really prove.
Microsoft and A16Z set aside differences, join hands in plea against AI regulation | TechCrunch
Two of the biggest forces in two deeply intertwined tech ecosystems — large incumbents and startups — have taken a break from counting their money…
How Close Are We to Reversing Aging?
Discover the latest research on anti-aging pills. Experts discuss options like metformin, ra-pamycin, NAD+ and HRT, exploring their potential to slow down aging.
Omega-3 and 6 Linked to Lower Cancer Risk – Neuroscience News
Higher levels of omega-3 and omega-6 fatty acids are linked with a lower risk of several types of cancer, including brain, colon, stomach, and lung…
On Second Thought: Aspirin for Primary Prevention — What We Really Know
Dr Christopher Labos discusses considerations for the benefits and risks of aspirin use in adults for primary prevention.
Science was meant to disprove religion- it’s making God more likely
DailyMail.com has heard from scientists in other fields whose life-long pursuit of empirical truth in the lab has led them to ‘believe in God as…
This elephant learned to use a hose as a shower. Then her rival sought revenge
Behaviors reveal sophisticated tool use—and possible “pranking”—among pachyderms
On Second Thought: Aspirin for Primary Prevention — What We Really Know
Dr Christopher Labos discusses considerations for the benefits and risks of aspirin use in adults for primary prevention.